HIF1a + PDK1 Hypoxia Response Human Flow Cytometry Kit (ab126700)

Overview

  • Product name
    HIF1a + PDK1 Hypoxia Response Human Flow Cytometry Kit
  • Detection method
    Fluorescent
  • Sample type
    Adherent cells, Suspension cells
  • Assay type
    Sandwich
  • Species reactivity
    Reacts with: Human
  • Product overview

    Hypoxia and the cellular response to hypoxic environment are central topics in studies of metabolism, cancer progression and development and stem cells. A key player is the transcription factor HIF1 alpha (hypoxia inducible factor 1 alpha) which is stabilized at the protein level in response to decreased oxygen tension. HIF1 alpha then promotes transcription of a number of factors that alters cellular physiology. This Hypoxic Response Human Flow Cytometry Kit provides duplexed measurements of the transcription factor HIF1 alpha and the HIF1 alpha responsive protein PDK1.

  • Tested applications
    Suitable for: Flow Cytmore details
  • Platform
    Reagents

Properties

Applications

Our Abpromise guarantee covers the use of ab126700 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
Flow Cyt Use at an assay dependent concentration.

Images

  • Figure 5. Antibody specificity demonstrated by Western Blot. Primary antibodies used in this assay kit were validated by western blot using HeLa cell lysates that had been treated with a dose titration of DFO as indicated. (A) The HIF1 alpha band (indicated by arrow) is absent in untreated cells and induced in a dose-dependent manner by DFO. (B) Similarly, PDK1 levels are increased by DFO treatment in a dose-dependent manner.
  • Figure 4. Antibody specificity demonstrated by immunocytochemistry. Primary antibodies used in this assay kit were validated by staining HeLa cells +/- treatment with 1mM DFO (24h) and imaged by fluorescent microscopy. PDK1 staining labels cellular mitochondria and the fluorescent intensity increases with DFO treatment.
  • Figure 2. Sample experiment using ab126700 on HeLa cells treated with a titration of DFO: PDK1 readout. HeLa cells were cultured in standard tissue culture plates and treated with a titration of DFO. After 24 hours of DFO exposure, the cells were harvested, fixed and stained as described in the protocol. (A) Flow cytometry histogram showing mean fluorescent intensity of PDK1 staining for untreated (Vehicle) and DFO treated samples. In this experiment anti-mouse-DyLight®488 (ab96879, 1:1000) was used as the secondary antibody and the signal was collected in FL1. (B) Plot showing fold induction of PDK1 levels (relative to untreated cells) as a function of DFO concentration (blue line). The gray dotted line demarks 1 (the untreated level). DFO concentrations =10µM induce PDK1 protein levels in a dose dependent manner.
  • Figure 3. Antibody specificity demonstrated by immunocytochemistry. Primary antibodies used in this assay kit were validated by staining HeLa cells +/- treatment with 1mM DFO (24h) and imaged by fluorescent microscopy. HIF1 alpha staining is absent in untreated cells and induced by DFO treatment. HIF1 alpha localizes to the nucleus (as seen by co-localization with the DNA stain DAPI) as expected.
  • Figure 1. Sample experiment using ab126700 on HeLa cells treated with a titration of DFO: HIF1 alpha readout. HeLa cells were cultured in standard tissue culture plates and treated with a titration of DFO. After 24 hours of DFO exposure, the cells were harvested, fixed and stained as described in the protocol. (A) Flow cytometry histogram showing mean fluorescent intensity of HIF1 alpha staining for untreated (Vehicle) and DFO treated samples. In this experiment anti-rabbit-DyLight®650 (ab96902, 1:2000) was used as the secondary antibody and the signal was collected in FL4. (B) Plot showing fold induction of HIF1 alpha levels (relative to untreated cells) as a function of DFO concentration (red line). The gray dotted line demarks 1 (the untreated level). DFO concentrations =10µM induce HIF1A protein levels in a dose dependent manner.

Protocols

References

ab126700 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab126700.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up